Literature DB >> 6497170

Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in ventilated patients.

J Chastre, F Viau, P Brun, J Pierre, M C Dauge, A Bouchama, A Akesbi, C Gibert.   

Abstract

To determine the relative cultural accuracy of the bronchoscopic protected specimen brush (PSB) in ventilated patients, we compared this method in the same area of the lung with histologic and bacteriologic examinations of pulmonary specimens. The procedures were concluded just after death when the ventilator was still functioning. Samples via the PSB were taken from a branch of the anterior basal bronchus of the left lower lobe, and immediate left thoracotomy was performed to obtain peripheral specimens from the corresponding segment for quantitative cultures. Twenty-six patients were studied; 6 had histologically proved pneumonia. Using quantitative cultures, a correlation was evidenced between PSB and lung cultures, especially in the subgroup of patients who received no antibiotic during the week preceding their death. No pneumonia was observed when PSB cultures isolated no organisms in concentrations greater than 10(3) colony-forming units (cfu) per ml. The PSB cultures at a level of 10(3) cfu/ml identified every patient with histologically proved pneumonia and every microorganism present in concentrations of 10(4) cfu/g or greater in the lungs. Moreover, in the subgroup of patients receiving no antibiotic, only 4 microorganisms were isolated by the PSB in concentrations greater than 10(3) cfu/ml and not found in the lung.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1984        PMID: 6497170     DOI: 10.1164/arrd.1984.130.5.924

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  60 in total

Review 1.  Histopathology of ventilator-associated pneumonia (VAP) and its clinical implications.

Authors:  A Torres; N Fábregas; Y Arce; M A López-Boado
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

Review 2.  Nosocomial pneumonia in the intensive care unit: mechanisms and significance.

Authors:  C A'Court; C S Garrard
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

Review 3.  Procedures for the diagnosis of pneumonia in ICU patients.

Authors:  J Chastre; J Y Fagon; C Lamer
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

4.  Continuous positive airway pressure by face mask or mechanical ventilation in patients with human immunodeficiency virus infection and severe Pneumocystis carinii pneumonia.

Authors:  B Gachot; B Clair; M Wolff; B Régnier; F Vachon
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 5.  Evaluation of the available invasive and non-invasive techniques for diagnosing nosocomial pneumonias in mechanically ventilated patients.

Authors:  A Torres; J González; M Ferrer
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

6.  Diagnosis of ventilator-acquired Pneumonia: Where Do We Go From Here?

Authors:  B Lynn Johnston; John M Conly
Journal:  Can J Infect Dis       Date:  2003-03

7.  Use of a protected catheter brush for culture of the lower respiratory tract in horses with small airway disease.

Authors:  L Grandguillot; J M Fairbrother; A Vrins
Journal:  Can J Vet Res       Date:  1991-01       Impact factor: 1.310

8.  Is penicillin G an adequate initial treatment for aspiration pneumonia? A prospective evaluation using a protected specimen brush and quantitative cultures.

Authors:  L Mier; D Dreyfuss; B Darchy; J J Lanore; K Djedaïni; P Weber; P Brun; F Coste
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

9.  High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome.

Authors:  S Chollet-Martin; P Montravers; C Gibert; C Elbim; J M Desmonts; J Y Fagon; M A Gougerot-Pocidalo
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

10.  Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

Authors:  M P Fink; D R Snydman; M S Niederman; K V Leeper; R H Johnson; S O Heard; R G Wunderink; J W Caldwell; J J Schentag; G A Siami
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.